PubRank

Peter C Richmond

Author PubWeight™ 40.29‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Neurologic complications of influenza A(H1N1)pdm09: surveillance in 6 pediatric hospitals. Neurology 2012 1.65
2 Hospitalisation for bronchiolitis in infants is more common after elective caesarean delivery. Arch Dis Child 2011 1.56
3 Phase I and II randomised trials of the safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in healthy adults. Vaccine 2008 1.52
4 Molecular surveillance of true nontypeable Haemophilus influenzae: an evaluation of PCR screening assays. PLoS One 2012 1.42
5 Safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in infants and children. Vaccine 2008 1.40
6 Antibody persistence in Australian adolescents following meningococcal C conjugate vaccination. Pediatr Infect Dis J 2015 1.38
7 Vaccine Effectiveness Against Laboratory-confirmed Influenza in Healthy Young Children: A Case-Control Study. Pediatr Infect Dis J 2011 1.07
8 Nasopharyngeal carriage of Haemophilus haemolyticus in otitis-prone and healthy children. J Clin Microbiol 2010 1.07
9 Neonatal pneumococcal conjugate vaccine immunization primes T cells for preferential Th2 cytokine expression: a randomized controlled trial in Papua New Guinea. Vaccine 2009 1.04
10 Safety and immunogenicity of a meningococcal B bivalent rLP2086 vaccine in healthy toddlers aged 18-36 months: a phase 1 randomized-controlled clinical trial. Pediatr Infect Dis J 2012 1.02
11 Maternal antibodies to pneumolysin but not to pneumococcal surface protein A delay early pneumococcal carriage in high-risk Papua New Guinean infants. Clin Vaccine Immunol 2009 1.02
12 Neutrophil extracellular traps and bacterial biofilms in middle ear effusion of children with recurrent acute otitis media--a potential treatment target. PLoS One 2013 0.99
13 Neonatal innate cytokine responses to BCG controlling T-cell development vary between populations. J Allergy Clin Immunol 2009 0.98
14 A phase 2 open-label safety and immunogenicity study of a meningococcal B bivalent rLP2086 vaccine in healthy adults. Vaccine 2013 0.94
15 Multi-species bacterial biofilm and intracellular infection in otitis media. BMC Pediatr 2011 0.94
16 Household transmission of respiratory viruses - assessment of viral, individual and household characteristics in a population study of healthy Australian adults. BMC Infect Dis 2012 0.93
17 A randomized, controlled, phase 1/2 trial of a Neisseria meningitidis serogroup B bivalent rLP2086 vaccine in healthy children and adolescents. Pediatr Infect Dis J 2013 0.93
18 Safety and immunogenicity of an inactivated thimerosal-free influenza vaccine in infants and children. Influenza Other Respir Viruses 2009 0.92
19 Virus detection and its association with symptoms during influenza-like illness in a sample of healthy adults enrolled in a randomised controlled vaccine trial. Influenza Other Respir Viruses 2012 0.90
20 Lessons from the first year of the WAIVE study investigating the protective effect of influenza vaccine against laboratory-confirmed influenza in hospitalised children aged 6-59 months. Influenza Other Respir Viruses 2010 0.89
21 Reduction in disparity for pneumonia hospitalisations between Australian Indigenous and non-Indigenous children. J Epidemiol Community Health 2011 0.88
22 High detection rates of nucleic acids of a wide range of respiratory viruses in the nasopharynx and the middle ear of children with a history of recurrent acute otitis media. J Med Virol 2011 0.88
23 Neonatal antigen-presenting cells are functionally more quiescent in children born under traditional compared with modern environmental conditions. J Allergy Clin Immunol 2012 0.88
24 Using SMS to monitor adverse events following trivalent influenza vaccination in pregnant women. Aust N Z J Obstet Gynaecol 2014 0.86
25 Are you listening? The inaugural Australian Otitis Media (OMOZ) workshop--towards a better understanding of otitis media. Med J Aust 2010 0.86
26 Safety and immunogenicity of neonatal pneumococcal conjugate vaccination in Papua New Guinean children: a randomised controlled trial. PLoS One 2013 0.85
27 Nasopharyngeal carriage of Streptococcus pneumoniae: prevalence and risk factors in HIV-positive children in Tanzania. Int J Infect Dis 2012 0.83
28 Febrile convulsions after 2010 seasonal trivalent influenza vaccine: implications for vaccine safety surveillance in Australia. Med J Aust 2010 0.83
29 Ensuring safety of the 2011 trivalent influenza vaccine in young children. Med J Aust 2011 0.83
30 Safety surveillance of influenza vaccine in pregnant women. Aust N Z J Obstet Gynaecol 2013 0.83
31 Inflammatory and haematological markers in the maternal, umbilical cord and infant circulation in histological chorioamnionitis. PLoS One 2012 0.82
32 Safety and tolerability of a 2009 trivalent inactivated split-virion influenza vaccine in infants, children and adolescents. Influenza Other Respir Viruses 2013 0.81
33 Timing of bronchiolitis hospitalisations and respiratory syncytial virus immunoprophylaxis in non-metropolitan Western Australia. Med J Aust 2009 0.81
34 Reactogenicity of two 2010 trivalent inactivated influenza vaccine formulations in adults. Vaccine 2011 0.80
35 Children with otitis media mount a pneumococcal serotype specific serum IgG and IgA response comparable to healthy controls after pneumococcal conjugate vaccination. Vaccine 2012 0.79
36 IgG responses to Pneumococcal and Haemophilus influenzae protein antigens are not impaired in children with a history of recurrent acute otitis media. PLoS One 2012 0.79
37 New findings in the pathogenesis of otitis media. Laryngoscope 2012 0.78
38 Pneumococcal conjugate vaccination at birth in a high-risk setting: no evidence for neonatal T-cell tolerance. Vaccine 2011 0.78
39 Influenza Vaccine Effectiveness and Uptake in Children at Risk of Severe Disease. Pediatr Infect Dis J 2016 0.77
40 Clinical epidemiology and predictors of outcome in children hospitalised with influenza A(H1N1)pdm09 in 2009: a prospective national study. Influenza Other Respir Viruses 2014 0.77
41 High pneumococcal serotype specific IgG, IgG1 and IgG2 levels in serum and the middle ear of children with recurrent acute otitis media receiving ventilation tubes. Vaccine 2013 0.77
42 A practical method for preparation of pneumococcal and nontypeable Haemophilus influenzae inocula that preserves viability and immunostimulatory activity. BMC Res Notes 2013 0.77
43 Linking Indigenous health care with school education. Med J Aust 2009 0.75